Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

PERRIGO COMPANY PLC

(PRGO)
  Report
Delayed Quote. Delayed Nyse - 12/03 04:10:00 pm
35.79 USD   -0.11%
12/02PERRIGO COMPANY PLC : Ex-dividend day for
FA
11/25Company valuations and climate strategies are poles apart
RE
11/22Perrigo to Delist From Tel Aviv Stock Exchange
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Perrigo Company plc
Perrigo Company plc is a provider of over the counter (OTC) health and wellness solutions that enables consumers to prevent or treat conditions that can be self-managed. The Company operates through two segments: Consumer Self-Care Americas (CSCA) and Consumer Self-Care International (CSCI). The CSCA segment comprises consumer self-care business (OTC, infant formula, and oral self-care categories, and contract manufacturing) in the United States (U.S), Mexico and Canada. CSCA segment products sold under brands, such as Prevacid 24HR, Good Sense, Zephrex D, ScarAway, Plackers, Rembrandt, Steripod and Firefly. The CSCI segment comprises consumer self-care business primarily branded in Europe and Australia, store brand business in the United Kingdom and parts of Europe and Asia. The CSCI segment primarily focuses on building local and regional brands sold through merchandisers, drug stores, pharmacies and e-commerce channels.

Number of employees : 11 500 people.
Sales per Business
20192020Delta
Consumer Self-Care Americas2 487.7051.4%2 693.0053.2% +8.25%
Consumer Self-Care International1 382.2028.6%1 395.2027.6% +0.94%
Prescription Pharmaceuticals967.5020%975.1019.3% +0.79%
USD in Million
Sales per region
20192020Delta
United States3 225.6066.7%3 441.1068% +6.68%
Europe1 312.4027.1%1 320.8026.1% +0.64%
All Other Countries276.005.7%271.605.4% -1.59%
Ireland23.400.5%29.800.6% +27.35%
USD in Million
Managers
Name Title Age Since
Murray Kessler President, Chief Executive Officer & Director 60 2018
Raymond Silcock CFO, Principal Accounting Officer & Executive VP 69 2019
Thomas Farrington Chief Information Officer & Executive VP 62 2015
Grainne Quinn Chief Medical Officer & Executive Vice President 50 2016
Donal M. O'Connor Independent Director 69 2014
Geoffrey M. Parker Independent Director 55 2016
Theodore Rapp Samuels Independent Director 65 2017
Bradley A. Alford Independent, Director 63 2017
Jeffrey B. Kindler Independent Director 64 2017
Adriana Karaboutis Independent Director 57 2017
Members of the board
Name Title Age Since
Rolf Classon Chairman 75 2018
Donal M. O'Connor Independent Director 69 2014
Geoffrey M. Parker Independent Director 55 2016
Theodore Rapp Samuels Independent Director 65 2017
Bradley A. Alford Independent, Director 63 2017
Jeffrey B. Kindler Independent Director 64 2017
Adriana Karaboutis Independent Director 57 2017
Murray Kessler President, Chief Executive Officer & Director 60 2018
Erica L. Mann Independent Director 61 2019
Katherine C. Doyle Independent Director 52 2020
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 133,773,881 132,789,058 99.3% 0 0.0% 99.3%
Shareholders
NameEquities%
The Vanguard Group, Inc. 13,428,581 10.0%
Barrow, Hanley, Mewhinney & Strauss LLC 7,232,440 5.41%
T. Rowe Price Associates, Inc. (Investment Management) 4,249,300 3.18%
Starboard Value LP 4,100,000 3.07%
Southeastern Asset Management, Inc. 4,038,200 3.02%
SSgA Funds Management, Inc. 4,001,542 2.99%
BlackRock Fund Advisors 3,652,947 2.73%
Carmignac Gestion SA 3,224,624 2.41%
The London Company of Virginia LLC 3,199,326 2.39%
Dimensional Fund Advisors LP 3,080,749 2.30%
Company contact information
Perrigo Co. Plc
The Sharp Building
Hogan Place
Dublin 2

Phone : +353.1.709.4000
Web : http://www.perrigo.com
Brand Portfolio
In partnership withAllbrands.markets
More brands of Perrigo Company plc
Sector Other Pharmaceuticals
1st jan.Capi. (M$)
PERRIGO COMPANY PLC-19.88%4 788
JOHNSON & JOHNSON1.27%419 583
ROCHE HOLDING AG17.62%341 364
PFIZER, INC.44.09%304 610
NOVO NORDISK A/S64.51%244 010
ELI LILLY AND COMPANY47.55%222 641
ABBVIE INC.8.18%210 113
MERCK & CO., INC.-10.34%185 253
NOVARTIS AG-12.05%179 058
ASTRAZENECA PLC11.84%167 779
BRISTOL-MYERS SQUIBB COMPANY-9.21%125 010
SANOFI6.44%118 698
AMGEN INC.-11.95%114 028
GLAXOSMITHKLINE PLC14.35%101 616
CHUGAI PHARMACEUTICAL CO., LTD.-33.20%53 454
JIANGSU HENGRUI MEDICINE CO., LTD.-47.03%49 171
BAYER AG-8.10%49 077
DAIICHI SANKYO COMPANY, LIMITED-19.48%48 251
TAKEDA PHARMACEUTICAL COMPANY LIMITED-18.24%42 287
ASTELLAS PHARMA INC.11.79%29 201
HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY36.49%22 646